Lupin Deal Spree Continues, Looks ‘Down Under’ For Generic Growth
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Three weeks after it announced the acquisition of German generic firm Hormosan, the world's largest manufacturer of anti-TB drugs - Lupin - has bought a minority stake in Australian drug maker Generic Health (PharmAsia News, July 31, 2008)